| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.45B | +4.9% | +27.3% |
| R&D Expense | $355.0M | +1.1% | +22.8% |
| SG&A Expense | $400.0M | +3.1% | +27.0% |
| Operating Income | $258.0M | +58.3% | +141.1% |
| Pre-tax Income | $248.0M | -8.5% | +60.0% |
| Income Tax | $5.0M | +138.5% | +183.3% |
| Net Income | $244.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.28B | -16.2% | -10.5% |
| Accounts Receivable | $894.0M | +6.4% | +43.7% |
| Current Assets | $10.49B | +7.8% | +55.2% |
| Total Assets | $17.97B | +6.0% | +46.4% |
| Current Liabilities | $5.13B | +9.3% | +25.4% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.01B | — | — |
| Capital Expenditures | $203.0M | — | — |
| Investing Cash Flow | -$1.27B | — | — |
| Financing Cash Flow | $2.38B | — | — |
| Free Cash Flow | $1.81B | — | — |
| -14.4% |
| +50.6% |
| EPS (Basic) | $0.57 | -14.9% | +46.2% |
| EPS (Diluted) | $0.55 | -15.4% | +44.7% |
| $8.46B |
| +5.5% |
| +80.1% |
| Stockholders' Equity | $9.49B | +6.4% | +25.4% |